Alzamend Neuro Inc (ALZN) 財務データ
*すべての数値は百万単位です
| 期間終了日 | 2026-07-31 | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 |
|---|---|---|---|---|---|
| 期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
5.38%3.03 | 2.87 | 2.20 | 1.00 | 2.70 | |
| Research and Development | 150.23%1.09 | 0.43 | 1.28 | 0.18 | 1.74 |
| Interest Income/Expense | 1,237%0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income/Loss | 5.38%-3.03 | -2.87 | -2.20 | -1.00 | -2.70 |
| Nonoperating Income/Loss | 273.06%-0.00 | 0.00 | -0.00 | -0.00 | -0.00 |
120.59%-3.03 | 14.70 | -2.20 | -1.00 | 2.70 | |
| Attributable To Parent | 5.47%-3.03 | -2.87 | -2.20 | -1.00 | -2.70 |
| Available To Common Stockholders, Basic | 204.53%3.00 | -2.87 | -2.20 | -1.00 | -2.70 |
| Basic Average Shares | 4.48 | - | 3.80 | 3.38 | 2.11 |
| Diluted Average Shares | 4.48 | - | 3.80 | 3.38 | 2.11 |
| Basic Earnings Per Share | -0.68 | - | -0.58 | -0.30 | -1.28 |
| Diluted Earnings Per Share | -0.68 | - | -0.58 | -0.30 | -1.28 |